Tags

FDA Seeks to Pull Vasculitis Drug Tavneos Over Alleged Trial Data Manipulation; Amgen Disputes the Claim

The FDA says Tavneos was approved on the basis of manipulated trial data and has proposed withdrawing it, while Amgen insists the drug works. The EU has already removed it and the UK plans to follow.